NETGEAR Products Win Six Red Dot Awards for Innovative Product Design in Global Competition
Apr 11, 2017 12:30 pm UTC| Business
SAN JOSE, Calif., April 11, 2017 -- NETGEAR®, Inc. (NASDAQ:NTGR), the worldwide leader of smart home security and networking products for both home and small businesses, has been recognized for its dedication to the...
EnerNOC Recognized as 2017 ENERGY STAR® Partner of the Year
Apr 11, 2017 12:28 pm UTC| Business
BOSTON, April 11, 2017 -- EnerNOC, Inc. (Nasdaq:ENOC), a leading provider of energy intelligence software (EIS) and demand response solutions, today announced that it has been recognized by the U.S. Environmental...
Apr 11, 2017 12:27 pm UTC| Business
CAMBRIDGE, Mass., April 11, 2017 -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that it has been awarded the World...
StrikeForce’s GuardedID® & MobileTrust® Products Will Launch on HSN on April 15th
Apr 11, 2017 12:23 pm UTC| Business
EDISON, N.J., April 11, 2017 -- StrikeForce Technologies, Inc. (OTC PINK:SFOR) announced today that its GuardedID MobileTrust security software products will launch on leading entertainment and lifestyle retailer, HSN,...
Apr 11, 2017 12:15 pm UTC| Business
MIDLAND PARK, N.J., April 11, 2017 -- Stewardship Financial Corporation (NASDAQ:SSFN) (the “Corporation”), the parent company of Atlantic Stewardship Bank serving Northern New Jersey, today announced the pricing of an...
RECORDATI: SHAREHOLDERS APPROVE THE 2016 ACCOUNTS. DIVIDEND € 0.70 PER SHARE (+16.7% vs 2015)
Apr 11, 2017 12:12 pm UTC| Business
Shareholders approve the 2016 results: consolidated revenues € 1,153.9 million (+10.1% vs 2015), operating income € 327.4 million (+17.6%), net income € 237.4 million (+19.4%). Dividend for 2016 € 0.70 per share (+16.7%...
Key Milestone Reached in Catalyst’s Subcutaneous Factor IX Program
Apr 11, 2017 12:02 pm UTC| Business
-- Milestone payment received with completion of IND-enabling toxicology studies -- -- Catalyst’s collaborator, ISU Abxis, plansto initiate a Phase 1/2 proof-of-concept study in individuals with severe hemophilia B in...